/
/
Carl Gordon, Ph.D.
1/1
Number of views:
1000

Carl Gordon, Ph.D.

Founding Partner of Orbimed
From 2014 to 2019, for five consecutive years, was named the "World's Top 100 Venture Capitalists" by Forbes magazine
Ph.D. in Molecular Biology, Massachusetts Institute of Technology
Bachelor of Science, Harvard; Chartered Financial Analyst
Dr. Carl Gordon is a founding partner of Orbimed and leads Orbimed’s global private equity team. He has served on a number of NASDAQ-listed companies, including Alector Inc. (Stock code: ALEC), Turning Point Therapeutics, Inc. (Stock code: TPTX), Prevail Therapeutics, Inc. (Stock code: PRVL), X4 Pharmaceuticals, Inc. (formerly Arsanis, Inc.) (Stock Code: XFOR), Acceleron Pharma Inc., (Stock Code: XLRN), ARMO BioSciences, Inc. (Stock code: ARMO), Intellia Therapeutics, Inc. (Stock code: NTLA), Selecta Biosciences, Inc. (Stock code: SELB), SpringWorks Therapeutics, Inc. (Stock code: SWTX) and Passage Bio Inc. (Stock code: PASG).
Retail price
0.0
Market price
0.0
Number of views:
1000
Product serial number
Quantity
-
+
1
Resume description

  Ø Founding Partner of Orbimed

  Ø From 2014 to 2019, for five consecutive years, was named the "World's Top 100 Venture Capitalists" by Forbes magazine

  Ø Ph.D. in Molecular Biology, Massachusetts Institute of Technology

  Ø Bachelor of Science, Harvard; Chartered Financial Analyst

Dr. Carl Gordon is a founding partner of Orbimed and leads Orbimed’s global private equity team.  He has served on a number of NASDAQ-listed companies, including Alector Inc. (Stock code: ALEC), Turning Point Therapeutics, Inc. (Stock code: TPTX), Prevail Therapeutics, Inc. (Stock code: PRVL), X4 Pharmaceuticals, Inc. (formerly Arsanis, Inc.) (Stock Code: XFOR), Acceleron Pharma Inc., (Stock Code: XLRN), ARMO BioSciences, Inc. (Stock code: ARMO), Intellia Therapeutics, Inc. (Stock code: NTLA), Selecta Biosciences, Inc. (Stock code: SELB), SpringWorks Therapeutics, Inc. (Stock code: SWTX) and Passage Bio Inc. (Stock code: PASG).

We could not find any corresponding parameters, please add them to the properties table
Copyright ©2021-2029 Frontera Therapeutics Inc. All Rights Reserved.